Cai Lie, Pfob André
Department of Obstetrics and Gynecology, Heidelberg University Hospital, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.
National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abdom Radiol (NY). 2025 Apr;50(4):1775-1789. doi: 10.1007/s00261-024-04640-x. Epub 2024 Nov 2.
In recent years, the integration of artificial intelligence (AI) techniques into medical imaging has shown great potential to transform the diagnostic process. This review aims to provide a comprehensive overview of current state-of-the-art applications for AI in abdominal and pelvic ultrasound imaging.
We searched the PubMed, FDA, and ClinicalTrials.gov databases for applications of AI in abdominal and pelvic ultrasound imaging.
A total of 128 titles were identified from the database search and were eligible for screening. After screening, 57 manuscripts were included in the final review. The main anatomical applications included multi-organ detection (n = 16, 28%), gynecology (n = 15, 26%), hepatobiliary system (n = 13, 23%), and musculoskeletal (n = 8, 14%). The main methodological applications included deep learning (n = 37, 65%), machine learning (n = 13, 23%), natural language processing (n = 5, 9%), and robots (n = 2, 4%). The majority of the studies were single-center (n = 43, 75%) and retrospective (n = 56, 98%). We identified 17 FDA approved AI ultrasound devices, with only a few being specifically used for abdominal/pelvic imaging (infertility monitoring and follicle development).
The application of AI in abdominal/pelvic ultrasound shows promising early results for disease diagnosis, monitoring, and report refinement. However, the risk of bias remains high because very few of these applications have been prospectively validated (in multi-center studies) or have received FDA clearance.
近年来,将人工智能(AI)技术整合到医学成像中已显示出极大的潜力来改变诊断过程。本综述旨在全面概述AI在腹部和盆腔超声成像中的当前先进应用。
我们在PubMed、FDA和ClinicalTrials.gov数据库中搜索AI在腹部和盆腔超声成像中的应用。
通过数据库搜索共识别出128个标题,符合筛选条件。筛选后,57篇手稿被纳入最终综述。主要的解剖学应用包括多器官检测(n = 16,28%)、妇科(n = 15,26%)、肝胆系统(n = 13,23%)和肌肉骨骼(n = 8,14%)。主要的方法学应用包括深度学习(n = 37,65%)、机器学习(n = 13,23%)、自然语言处理(n = 5,9%)和机器人(n = 2,4%)。大多数研究为单中心(n = 43,75%)且为回顾性研究(n = 56,98%)。我们识别出17种FDA批准的AI超声设备,其中只有少数专门用于腹部/盆腔成像(不孕症监测和卵泡发育)。
AI在腹部/盆腔超声中的应用在疾病诊断、监测和报告完善方面显示出有希望的早期结果。然而,偏倚风险仍然很高,因为这些应用中很少有经过前瞻性验证(在多中心研究中)或获得FDA批准。